MILESTONE SCIENTIFIC INC. — fact timeline

MILESTONE SCIENTIFIC INC. engaged Grassi & Co., CPAs, P.C. as its auditor.

“The Company engaged Grassi & Co., CPAs, P.C. to be the independent registered public accounting firm to the Company for”

MILESTONE SCIENTIFIC INC. dismissed CBIZ CPAs P.C. as its auditor.

“(the “Company”) approved the dismissal of CBIZ CPAs P.C. (“CBIZ CPAs”) as the independent registered public accounting firm to the Company effective as of May 15,”

MILESTONE SCIENTIFIC INC. entered into Purchase Agreement with the purchasers named therein (the "Purchasers") valued at $2,150,000 (effective 2026-04-20).

“On April 20, 2026, Milestone Scientific Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers named therein (the “Purchasers”), for the private placement (the “Private Placement”) of an aggregate of 7,962,963 units (the “Units”), with each Unit consisting of (i) one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (ii) one warrant to purchase one share of Common Stock (each, a “Warrant”).”

MILESTONE SCIENTIFIC INC. amended Amendment with Innovest S.p.A. (effective 2026-03-31).

“On March 31, 2026, Milestone Scientific Inc. (the “Company”) entered into an amendment (the “Amendment”) to the Amended and Restated Memorandum of Understanding, dated January 13, 2026 (the “MOU”), with Innovest S.p.A., as the holder of certain consent/blockage rights with respect to BP4 S.r.l., a society’ a responsibility’ limitation in liquidation (“BP4”).”

MILESTONE SCIENTIFIC INC.: The Company amended its Restated Certificate of Incorporation to increase authorized shares of common stock from 100,000,000 to 125,000,000 (effective 2026-03-10).

“As a result of the stockholder approval, the Company filed a Certificate of Amendment of its Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on March 10, 2026, which amendment became effective on filing.”

MILESTONE SCIENTIFIC INC. entered into Amended and Restated Memorandum of Understanding with Innovest S.p.A. (effective 2026-01-15).

“On January 15, 2026, Milestone Scientific Inc. (“the Company”) entered into an Amended and Restated Memorandum of Understanding (the “MOU”) with Innovest S.p.A., as the holder of certain consent/blockage rights with respect to BP4 S.r.l., a society’ a responsibility’ limitation in liquidation (“BP4”).”

MILESTONE SCIENTIFIC INC. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).

“October 8, 2025, Milestone Scientific Inc. (“the Company”) received a letter from NYSE American LLC (“NYSE American” or the “Exchange”) stating that the Company is not in compliance with the continued listing standards as outlined in Section(s) 1003(a)(ii), and (iii) of the NYSE American Company Guide (the “Company Guide”). To maintain its listing, the Company must submit a plan of compliance by November 7, 2025, outlining the actions it has taken or will take to regain compliance. If the plan is accepted, the Company may be able to continue its listing but will be subject to periodic reviews”

Shanth Thiyagalingam was appointed as independent director at MILESTONE SCIENTIFIC INC..

“On May 14, 2025, the Board of Directors of Milestone Scientific Inc. (the “Company”) unanimously by the directors in attendance appointed Shanth Thiyagalingam as an independent director of the Company.”

Giandomenico Trombetta resigned as Director at MILESTONE SCIENTIFIC INC..

“On January 12, 2025, Mr. Giandomenico Trombetta, a director of Milestone Scientific Inc. (the “Company”), advised the Chairman of the Board that he is resigning, effective immediately, as a director.”

Neal Goldman was appointed as Interim Chief Executive Officer at MILESTONE SCIENTIFIC INC..

“Mr. Neal Goldman, the Chairman of the Board of Directors of the Company, has been appointed the Interim Chief Executive Officer, effective on Mr. Haverhals retirement.”

Arjan Haverhals departed as Chief Executive Officer at MILESTONE SCIENTIFIC INC..

“On November 8, 2024, Mr. Arjan Haverhals, the Chief Executive Officer of Milestone Scientific Inc. (the “Company”), advised the Chairman of the Board that he intends to retire as an officer from the Company upon the expiration of, and not seek the renewal of, his employment agreement, on December 31, 2024.”